Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 552025 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 607864 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 751179 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 821837 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 831619 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 839874 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 869786 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 875901 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 876221 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 878133 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 883025 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 887825 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 895100 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 900931 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 909539 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 922713 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 937861 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 955406 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 961058 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 966731 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 981654 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 982308 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 982474 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1015321 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1018054 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1019085 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1031748 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1033725 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1042050 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1043205 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1053326 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1056644 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1060738 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1061735 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1064044 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1066397 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1078029 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1082601 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1091681 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1092693 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1094471 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1104440 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1115157 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1117091 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1117671 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1118724 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1119376 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1119446 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1135736 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1142568 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1151272 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1152087 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1152466 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1154664 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1157102 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1159398 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1175577 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1179153 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1193332 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1202999 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1216301 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1219303 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1236517 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1237128 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1241684 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1243530 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1244308 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1245121 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1251289 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1261087 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1282306 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1285278 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1289706 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1292083 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1292511 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1294109 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1300334 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1301561 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1331478 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1337782 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1355504 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1360528 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1368732 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1396205 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1396635 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1411894 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1412419 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1415058 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1426999 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1428373 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1438866 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1447749 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1475803 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1483179 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1517231 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1517937 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1599818 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1634561 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1643407 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 1645239 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 874716 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 954319 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1191465 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1237316 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1272214 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1272381 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1281106 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1339434 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1342150 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1352000 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1357052 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1379723 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1380461 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1382733 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1386351 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1423475 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1433536 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1436082 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1455513 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1499117 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1499984 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1510902 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1529589 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1531187 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1531463 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1538014 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1544050 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1551044 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1582166 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1594752 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1613682 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1618358 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1619801 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1625253 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1625621 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1626416 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1633189 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1636692 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1644803 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1645516 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1652666 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1656939 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1661526 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1665924 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1674104 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1686416 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1699631 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1714270 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1716903 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1717911 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1723398 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1744122 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1763369 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1767138 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1769433 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1777275 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1793117 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1808493 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1839274 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1842503 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1843586 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1858238 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1864113 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1865670 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1870438 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1877878 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1882801 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1884796 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1898751 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1903330 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1918710 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1950392 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1962863 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1979716 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1985048 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 1986221 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2025013 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2032061 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2034151 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2049359 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2060141 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2061792 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2086737 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2100439 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2131992 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2178332 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2191503 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2238284 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2244717 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2246055 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2253769 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2258892 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2321616 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2332716 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2417796 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2454807 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2521496 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2566614 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2574660 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 2621243 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Return to search page